Skip to main content
Premium Trial:

Request an Annual Quote

Research in the UK

Britain is tops among research-heavy nations, according to a report from the UK's Department for Business, Innovation, and Skills. While the UK accounts for 0.9 percent of the global population, it produces nearly 16 percent of the world's most highly cited papers, the Chronicle of Higher Education reports.
The BIS report, put together by Elsevier, examines the research activity and output, investment, and IP in the UK as compared to Canada, China, France, Germany, Italy, Japan, and the US as well as to rising researcher programs in Brazil, India and Russia.

"The UK is a highly productive research nation in terms of articles and citation outputs per researcher or per unit of R&D expenditure, resulting from a trend towards increasing outputs from broadly stable or decreasing inputs," the report says. "It is likely that recent increases in UK research productivity have, at least to some extent, been driven by the increase in UK international research collaboration, which is also associated with greater citation impact."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.